[{"address1": "2051 Ringwood Avenue", "city": "San Jose", "state": "CA", "zip": "95131", "country": "United States", "phone": "408 457 3700", "website": "https://www.ranitherapeutics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics for patients, physicians, and healthcare systems in the United States. The company develops the RaniPill capsule, a drug-agnostic oral delivery platform to deliver a variety of drug substances, including oligonucleotides, peptides, proteins, and antibodies. Its product pipeline includes RT-102, a parathyroid hormone that is in Phase I clinical trial for the treatment of osteoporosis; RT-105, an anti-TNF-alpha antibody that is in preclinical studies to treat psoriatic arthritis; RT-110, a parathyroid hormone for the treatment of hypoparathyroidism; and RT-111, an ustekinumab biosimilar for the treatment of various inflammatory conditions. The has a collaboration agreement with ProGen Co., Ltd. for the o-development and commercialization of RT-114 to treat obesity. Rani Therapeutics Holdings, Inc. was founded in 2012 and is headquartered in San Jose, California.", "fullTimeEmployees": 140, "companyOfficers": [{"maxAge": 1, "name": "Mr. Mir A. Imran", "age": 68, "title": "Executive Chairman", "yearBorn": 1956, "fiscalYear": 2023, "totalPay": 80000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Talat  Imran", "age": 42, "title": "CEO & Director", "yearBorn": 1982, "fiscalYear": 2023, "totalPay": 450000, "exercisedValue": 0, "unexercisedValue": 9180}, {"maxAge": 1, "name": "Mr. Svai S. Sanford", "age": 54, "title": "Chief Financial Officer", "yearBorn": 1970, "fiscalYear": 2023, "totalPay": 416000, "exercisedValue": 0, "unexercisedValue": 5173}, {"maxAge": 1, "name": "Dr. Mir  Hashim", "age": 64, "title": "Chief Scientific Officer", "yearBorn": 1960, "fiscalYear": 2023, "totalPay": 416000, "exercisedValue": 0, "unexercisedValue": 5427}, {"maxAge": 1, "name": "Mr. Alireza  Javadi", "title": "Vice President of Technical Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Eric  Groen J.D.", "age": 53, "title": "General Counsel", "yearBorn": 1971, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Bella  Vazquez", "title": "Vice President of Human Resources", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kate  McKinley M.B.A.", "age": 47, "title": "Chief Business Officer", "yearBorn": 1977, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Arvinder  Dhalla", "title": "Vice President of Clinical Development", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.46, "open": 1.53, "dayLow": 1.46, "dayHigh": 1.5392, "regularMarketPreviousClose": 1.46, "regularMarketOpen": 1.53, "regularMarketDayLow": 1.46, "regularMarketDayHigh": 1.5392, "payoutRatio": 0.0, "beta": 0.139, "forwardPE": -1.4950495, "volume": 58101, "regularMarketVolume": 58101, "averageVolume": 964826, "averageVolume10days": 163830, "averageDailyVolume10Day": 163830, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 88411104, "fiftyTwoWeekLow": 1.24, "fiftyTwoWeekHigh": 8.75, "fiftyDayAverage": 1.4854, "twoHundredDayAverage": 2.44938, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 56283428, "profitMargins": 0.0, "floatShares": 23289099, "sharesOutstanding": 33311500, "sharesShort": 2465452, "sharesShortPriorMonth": 1893158, "sharesShortPreviousMonthDate": 1738281600, "dateShortInterest": 1740700800, "sharesPercentSharesOut": 0.074, "heldPercentInsiders": 0.27313, "heldPercentInstitutions": 0.10855, "shortRatio": 1.22, "shortPercentOfFloat": 0.1224, "impliedSharesOutstanding": 58550400, "bookValue": 0.105, "priceToBook": 14.380953, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -28169000, "trailingEps": -1.05, "forwardEps": -1.01, "enterpriseToEbitda": -1.108, "52WeekChange": -0.5479042, "SandP52WeekChange": 0.09506309, "quoteType": "EQUITY", "currentPrice": 1.51, "targetHighPrice": 17.0, "targetLowPrice": 8.0, "targetMeanPrice": 11.5, "targetMedianPrice": 10.5, "recommendationKey": "none", "numberOfAnalystOpinions": 8, "totalCash": 30404000, "totalCashPerShare": 0.913, "ebitda": -50801000, "totalDebt": 33732000, "quickRatio": 1.504, "currentRatio": 1.602, "debtToEquity": 584.104, "returnOnAssets": -0.56799, "returnOnEquity": -2.7056699, "freeCashflow": -18851876, "operatingCashflow": -39319000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "RANI", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": 3.4246542, "regularMarketPrice": 1.51, "longName": "Rani Therapeutics Holdings, Inc.", "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1741996563, "regularMarketTime": 1741982401, "exchange": "NGM", "messageBoardId": "finmb_242425883", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "fiftyTwoWeekChangePercent": -54.79042, "earningsTimestampStart": 1742501100, "earningsTimestampEnd": 1742933100, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.05, "epsForward": -1.01, "epsCurrentYear": -1.01268, "priceEpsCurrentYear": -1.4910928, "fiftyDayAverageChange": 0.024600029, "fiftyDayAverageChangePercent": 0.016561216, "twoHundredDayAverageChange": -0.93937993, "twoHundredDayAverageChangePercent": -0.38351744, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-07-30", "cryptoTradeable": false, "shortName": "Rani Therapeutics Holdings, Inc", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1627651800000, "postMarketChangePercent": 1.96689, "postMarketPrice": 1.5397, "postMarketChange": 0.0297, "regularMarketChange": 0.049999952, "regularMarketDayRange": "1.46 - 1.5392", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 964826, "fiftyTwoWeekLowChange": 0.26999998, "fiftyTwoWeekLowChangePercent": 0.21774192, "fiftyTwoWeekRange": "1.24 - 8.75", "fiftyTwoWeekHighChange": -7.24, "fiftyTwoWeekHighChangePercent": -0.8274285, "displayName": "Rani Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-03-15"}]